ACR Appropriateness Criteria on Resectable Rectal Cancer. Expert Panel on Radiation Oncology-Rectal/Anal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 5, 2008, Pages 1427-1430

  Suh, W Warren ^a   Blackstock, A William ^b   Herman, Joseph ^c   Konski, Andre A ^d   Mohiuddin, Mohammed ^b,e   Poggi, Matthew M ^f   Regine, William F ^g   Cosman, Bard C ^h   Saltz, Leonard ⁱ   Johnstone, Peter A S ^j  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^f Inova Alexandria Cancer Center   (United States)

^g UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Appropriateness criteria; Chemotherapy; Radiotherapy; Rectal cancer

Indexed keywords

CHEMOTHERAPY; RADIOLOGY; RADIOTHERAPY;

APPROPRIATENESS CRITERIA; RECTAL CANCER;

ONCOLOGY;

FLUOROURACIL;

ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPARATIVE STUDY; HEALTH CARE ORGANIZATION; HUMAN; OVERALL SURVIVAL; PATIENT CARE; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM CANCER;

COMBINED MODALITY THERAPY; HUMANS; RECTAL NEOPLASMS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 40949165051     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.09.029     Document Type: Article

References (16)

1. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
2. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324 (1991) 709-715
3. Thomas P.R., and Lindblad A.S. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: A review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 13 (1988) 245-252
4. Tveit K.M., Guldvog I., Hagen S., et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84 (1997) 1130-1135
5. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331 (1994) 502-507
6. Smalley S.R., Benedetti J.K., Williamson S.K., et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24 (2006) 3542-3547
7. Tepper J.E., O'Connell M.J., Petroni G.R., et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of intergroup 0114. J Clin Oncol 15 (1997) 2030-2039
8. Lee J.H., Lee J.H., Ahn J.H., et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report. J Clin Oncol 20 (2002) 1751-1758
9. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336 (1997) 980-987
10. Birgisson H., Pahlman L., Gunnarsson U., et al. Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23 (2005) 8697-8705
11. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
12. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
13. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
14. Roh M.S., Colangelo L., Wieand S., et al. Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. J Clin Oncol 22 (2004) 3505
15. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: A pooled analysis. Int J Radiat Oncol Biol Phys 54 (2002) 386-396
16. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22 (2004) 1785-1796